Study of Sildenafil Citrate on Insulin Resistance in African American

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Metabolic SyndromeObesity
Interventions
DRUG

Sildenafil

20 mg three times a day.

DRUG

Placebo

No active drug

Trial Locations (1)

37232

Vanderbilt University, Nashville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Pfizer

INDUSTRY

lead

Vanderbilt University Medical Center

OTHER

NCT01334554 - Study of Sildenafil Citrate on Insulin Resistance in African American | Biotech Hunter | Biotech Hunter